• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

作者更正：特发性门静脉高压的影像学及病理特征与肝硬化的鉴别诊断

Author Correction: Imaging and Pathological Features of Idiopathic Portal Hypertension and Differential Diagnosis from Liver Cirrhosis.

作者信息

Zhao Zhen-Long, Wei Ying, Wang Tai-Ling, Peng Li-Li, Li Yan, Yu Ming-An

机构信息

Department of Interventional Ultrasound, China-Japan Friendship Hospital, Beijing, China.

Department of Pathology, China-Japan Friendship Hospital, Beijing, China.

出版信息

Sci Rep. 2020 Apr 30;10(1):7586. doi: 10.1038/s41598-020-63868-x.

DOI:10.1038/s41598-020-63868-x
PMID:32350347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7190623/
Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

摘要

本文的一个修订版本已发表，可通过本文顶部的链接获取。

相似文献

1
Author Correction: Imaging and Pathological Features of Idiopathic Portal Hypertension and Differential Diagnosis from Liver Cirrhosis.作者更正：特发性门静脉高压的影像学及病理特征与肝硬化的鉴别诊断
Sci Rep. 2020 Apr 30;10(1):7586. doi: 10.1038/s41598-020-63868-x.
2
Author Correction: Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.作者更正：重新评估肝硬化患者急性肾损伤和肝肾综合征的范围。
Nat Rev Nephrol. 2020 Mar;16(3):186. doi: 10.1038/s41581-020-0255-z.
3
Author Correction: MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis.作者更正：微小RNA-靶标网络分析确定了用于评估乙型肝炎所致肝硬化中医证候演变的潜在生物标志物。
Sci Rep. 2020 Apr 24;10(1):7217. doi: 10.1038/s41598-020-63940-6.
4
Author Correction: Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis.作者更正：尼达尼布对特发性肺纤维化患者的胃肠道不良反应及相关危险因素
Sci Rep. 2020 Jul 16;10(1):12080. doi: 10.1038/s41598-020-69088-7.
5
Author Correction: SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis.作者更正：血管内皮生长因子受体2的SUMO化修饰调节其细胞内运输及病理性血管生成。
Nat Commun. 2019 Aug 15;10(1):3679. doi: 10.1038/s41467-019-11659-y.
6
Author Correction: Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.作者更正：新型冠状病毒肺炎患者的病理性炎症：单核细胞和巨噬细胞的关键作用
Nat Rev Immunol. 2020 Jul;20(7):448. doi: 10.1038/s41577-020-0353-y.
7
Author Correction: Accelerating polygon beam with peculiar features.作者更正：加速具有独特特征的多边形光束。
Sci Rep. 2019 Nov 25;9(1):17817. doi: 10.1038/s41598-019-54457-8.
8
Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.作者更正：熊去氧胆酸通过苯丙氨酸/酪氨酸途径和肠道微生物群重塑改善肝功能不全患者的肝功能。
Sci Rep. 2019 Nov 13;9(1):17003. doi: 10.1038/s41598-019-53737-7.
9
Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly.86例特发性门静脉高压症的临床研究及与脾肿大性肝硬化的比较。
Gastroenterology. 1984 Apr;86(4):600-10.
10
Author Correction: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension.作者更正：KLF2诱导的外泌体微小RNA在肺动脉高压中的治疗潜力。
Nat Commun. 2020 Jun 30;11(1):3300. doi: 10.1038/s41467-020-17273-7.

引用本文的文献

1
Noninvasive differentiation of porto-sinusoidal vascular disorder from cirrhosis: a systematic review.非侵入性鉴别门腔静脉血管病变与肝硬化：系统综述。
Abdom Radiol (NY). 2023 Jul;48(7):2340-2348. doi: 10.1007/s00261-023-03927-9. Epub 2023 Apr 29.
2
Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography.磁共振弹性成像评估原发性硬化性胆管炎与病毒性肝炎肝纤维化的空间异质性。
Sci Rep. 2021 May 10;11(1):9820. doi: 10.1038/s41598-021-89372-4.